Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(60.0%)
Phase 2
1(20.0%)
Phase 3
1(20.0%)
5Total
Phase 1(3)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04631874Phase 1Completed

A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"

Role: lead

NCT02710994Phase 1Completed

Pharmacodynamics and Safety of CDFR0209

Role: collaborator

NCT02571101Phase 2Unknown

A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation

Role: lead

NCT02304523Phase 3Completed

Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy

Role: lead

NCT02028598Phase 1Completed

Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males

Role: lead

All 5 trials loaded